超越益生菌:探索后生菌和准生菌在兽医中的潜力
Seyede Hanieh Hosseini1, Azra Farhangfar2, Mehran Moradi3
1DVM Graduate, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
Research in veterinary science
|January 4, 2024
概括
后生物和准生物 (PP) 在动物健康中为抗生素提供了稳定,安全的替代品. 这些非活的微生物产品增强了牲畜和家禽的生长,免疫力和肠道健康.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 动物营养 动物营养
- 微生物学 微生物学
背景情况:
- 后生物 (生物活性化合物) 和准生物 (无活化的微生物细胞) 是从没有活微生物的发酵中获得的.
- 与益生菌不同,PP为动物卫生应用提供了增强的稳定性,安全性和功能多样性.
研究的目的:
- 审查目前关于兽医中后生物和准生物 (PP) 的研究.
- 检查PP在牲畜和家禽中的机制,益处和应用.
- 讨论制备方法,管理途径和PP利用的挑战.
主要方法:
- 关于动物健康中的后生物和准生物的综合文献综述.
- 对PP机制,有效性和安全性的研究进行分析.
- 探索PP在牲畜和家禽中的应用,包括给药途径.
主要成果:
- PP增强动物生长,改善胃肠道健康和免疫力,并有助于愈.
- PP显示出作为抗生素替代品的潜力,减轻了对抗菌素耐药性的担忧.
- 有效的施用途径包括料,饮用水和局部应用.
结论:
- 后生物和准生物在动物健康中是传统益生菌和抗生素的有希望的,稳定的替代品.
- 对PP制备和应用的进一步研究可以优化它们在兽医中的使用.
- 通过改善健康和减少对抗生素的依赖,PP有助于可持续的动物生产.
相关概念视频
What is Monogastric Digestion?
71.2K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.2K
The Central Dogma
21.7K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
21.7K
Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128


